To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
Already have an account?
Dalton Pharma and Boehringer Ingelheim Announce the Renewal of Chemistry Services Agreement
Read time: Less than a minute
Dalton Pharma Services announces the renewal of its Chemistry Services Agreement with Boehringer Ingelheim (Canada) Ltd.
Under the agreement Dalton will continue to provide chemistry services in support of Boehringer’s pharmaceutical development programs.
Peter Pekos, President of Dalton Pharma Services, said: “We are extremely pleased to continue our relationship with Boehringer Ingelheim (Canada) Ltd. The renewal of our chemistry services agreement demonstrates Boehringer Ingelheim’s deep commitment to research in Canada. We look forward to another successful collaboration with this world class organization.”
Under the agreement Dalton will continue to provide chemistry services in support of Boehringer’s pharmaceutical development programs.
Peter Pekos, President of Dalton Pharma Services, said: “We are extremely pleased to continue our relationship with Boehringer Ingelheim (Canada) Ltd. The renewal of our chemistry services agreement demonstrates Boehringer Ingelheim’s deep commitment to research in Canada. We look forward to another successful collaboration with this world class organization.”
